For heart failure or chronic kidney disease, the American Diabetes Association generally recommends SGLT2 inhibitors as first-line agents, with GLP-1 receptor agonists considered for their benefits on atherosclerotic cardiovascular disease, glycemic control, and weight management, or when SGLT2 inhibitors are not appropriate
Peripheral GLP-1 released after meals activates vagal afferent fibres that signal satiety to the brain
It plays a pivotal role in detoxification, immune support, and cellular health
There is growing evidence of the beneficial role of riboflavin in treating defects of riboflavin metabolism
And I got there, where I was the grass blade, and I felt the sun coming in and bubbling in me, and I felt myself organically reaching up to it